These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8633828)

  • 41. Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia.
    Barber BA; Pegram PS; High KP
    Clin Infect Dis; 1996 Oct; 23(4):718-22. PubMed ID: 8909833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
    Brun-Pascaud M; Chau F; Simonpoli AM; Girard PM; Derouin F; Pocidalo JJ
    J Infect Dis; 1994 Sep; 170(3):653-8. PubMed ID: 8077724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient.
    Cook DE; Kossey JL
    Ann Pharmacother; 1998 Dec; 32(12):1302-5. PubMed ID: 9876811
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current management practices in the treatment of Pneumocystis carinii pneumonia (PCP).
    Blanchet KD
    AIDS Patient Care STDS; 1996 Apr; 10(2):116-21. PubMed ID: 11361688
    [No Abstract]   [Full Text] [Related]  

  • 45. Advantages of dapsone over trimethoprim/sulfamethoxazole for Pneumocystis pneumonia prophylaxis in patients with immunobullous disease.
    Siscos SM; Neill BC; Tarantino IS; Aires DJ; Rajpara A
    J Am Acad Dermatol; 2021 Dec; 85(6):e325. PubMed ID: 30825531
    [No Abstract]   [Full Text] [Related]  

  • 46. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS.
    Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA
    Ann Intern Med; 1992 Jul; 117(2):106-11. PubMed ID: 1351371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic Pneumocystis carinii pneumonia prophylaxis with dapsone and pyrimethamine fails to protect against extrapulmonary pneumocystosis.
    Carlin EM; Coker RJ; Goldin RD; Harris JR
    Genitourin Med; 1993 Apr; 69(2):130-2. PubMed ID: 8509094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemoprophylaxis for Pneumocystis carinii pneumonia.
    Colebunders R; Denolf D; Verdonck K
    Pediatr Infect Dis J; 1999 Jul; 18(7):662. PubMed ID: 10440453
    [No Abstract]   [Full Text] [Related]  

  • 50. Use of fluoroquinolones for prophylaxis of murine Pneumocystis carinii pneumonia.
    Brun-Pascaud M; Fay M; Zhong M; Bauchet J; Dux-Guyot A; Pocidalo JJ
    Antimicrob Agents Chemother; 1992 Feb; 36(2):470-2. PubMed ID: 1605613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case of pneumocystis pneumonia after cessation of secondary prophylaxis.
    Quah SP; McBride M
    Int J STD AIDS; 2001 Feb; 12(2):126-7. PubMed ID: 11236102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
    J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.
    Falloon J; Lavelle J; Ogata-Arakaki D; Byrne A; Graziani A; Morgan A; Amantea MA; Ownby K; Polis M; Davey RT
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1580-7. PubMed ID: 7979291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment and prophylaxis of Pneumocystis carinii pneumonia.
    Castro M
    Semin Respir Infect; 1998 Dec; 13(4):296-303. PubMed ID: 9872626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in a cohort of 1000 patients with AIDS.
    Monforte AD; Mainini F; Bini T; Moscatelli GC; Antinori S; Formenti T; Testa L; Mena M; Moroni M
    J Chemother; 1995 Nov; 7 Suppl 4():184-6. PubMed ID: 8904150
    [No Abstract]   [Full Text] [Related]  

  • 56. Pneumocystis carinii pneumonia following discontinuation of primary prophylaxis despite highly active antiretroviral therapy.
    Mammen-Tobin A; Monteiro EF
    Int J STD AIDS; 2000 Jan; 11(1):64-5. PubMed ID: 10667904
    [No Abstract]   [Full Text] [Related]  

  • 57. Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus.
    Richards FO; Kovacs JA; Luft BJ
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S49-56. PubMed ID: 8547512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug-resistant Pneumocystis carinii.
    Meshnick SR
    Lancet; 1999 Oct; 354(9187):1318-9. PubMed ID: 10533856
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pyrimethamine and sulfadoxine as a preventive treatment for Pneumocystis carinii and Toxoplasma encephalitis].
    Teira R; Virosta M; Baraia-Etxaburu J; Muñoz J; Zubero Z; Cisterna R; Santamaría JM
    Enferm Infecc Microbiol Clin; 1999; 17(7):347-9. PubMed ID: 10535188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identifying the Cause of the "Saturation Gap": Two Cases of Dapsone-induced Methemoglobinemia.
    Furuta K; Ikeo S; Takaiwa T; Ikeda S; Nishiyama A; Yokoyama T; Ito A; Tokioka F; Tanaka M; Yoshioka H; Tachibana H; Arita M; Hashimoto T; Ishida T
    Intern Med; 2015; 54(13):1639-41. PubMed ID: 26134197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.